Zanoni, F., Naesens, M., Leal, R., Amoroso, A., Caliskan, Y., Keating, B., Gharavi, A., Castellano, G., Batal, I., & Kiryluk, K. (2024). #1450 Polygenic risk score of native IgA nephropathy predicts risk of post-transplant disease recurrence. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.184

Fakhouri, F., Bomback, A., Kavanagh, D., Remuzzi, G., Sunder-Plassmann, G., Kanellis, J., Daina, E., Walker, P., Wang, Z., & Ahmad, Z. (2024). #1467 Pegcetacoplan for post-transplant recurrent C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis in NOBLE: 12-week evolution. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.442

Schaefer, F., Al-Dakkak, I., Saval, N., Cohen, D., Greenbaum, L. A., & Ariceta, G. (2024). #243 Characteristics and safety in patients with atypical haemolytic uraemic syndrome switching to ravulizumab from eculizumab: a global registry analysis. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.011

Yap, E., Askanase, A., Kalunian, K., Dall’era, M., Hodge, L., Truman, M., & Solomons, N. (2024). #468 Voclosporin-based, triple-immunosuppressive therapy vs high-dose glucocorticoid-based dual-immunotherapy for lupus nephritis: a propensity analysis. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.136

Wooden, B., Tarragon, B., Navarro-Torres, M., & Bomback, A. S. (2023). Complement inhibitors for kidney disease. Nephrology Dialysis Transplantation, 38(Supplement_2), ii29–ii39. https://doi.org/10.1093/ndt/gfad079

Perkovic, V., Barratt, J., Radhakrishnan, J., Rizk, D., Trimarchi, H., Khawaja, Z., Leiske, J., Sorensen, B., King, A., Jones-Burton, C., & Campbell, K. (2023). #4333 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY. Nephrology Dialysis Transplantation, 38(Supplement_1). https://doi.org/10.1093/ndt/gfad063c_4333

Barbuto, S., Aghi, A., Cianciolo, G., La Manna, G., Tripepi, G. L., Pascale, K., Plebani, M., Zaninotto, M., Cosma, C., Gasperoni, L., Cortez, N., Nickolas, T., & Fusaro, M. (2023). #5440 BONE TURNOVER MARKERS AND BONE MINERAL DENSITY 1 YEAR AFTER KIDNEY TRANSPLANTATION. Nephrology Dialysis Transplantation, 38(Supplement_1). https://doi.org/10.1093/ndt/gfad063c_5440

Tsapepas, D., Sandra, V., Dale, L. A., Drexler, Y., King, K. L., Yu, M., Toma, K., Van Bever, J., Sanichar, N., Husain, S. A., & Mohan, S. (2022). Retrospective analysis of the impact of severe obesity on kidney transplant outcomes. Nephrology Dialysis Transplantation, 38(2), 472–480. https://doi.org/10.1093/ndt/gfac169

Rehnberg, J., Ludvigsson, J. F., Carrero, J.-J., & Emilsson, L. (2021). Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study. Nephrology Dialysis Transplantation, 37(4), 749–759. https://doi.org/10.1093/ndt/gfab322